Related Experiment Video
Updated: Sep 14, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT-based nomogram.
Neeraja Tillu1, Ashutosh Maheshwari2, Kaushik Kolanukuduru2
1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA. neeraja.tillu@mountsinai.org.
Prostate cancer (PCa) extraprostatic extension (EPE) prediction is improved using 18F-DCFPyL prostate-specific membrane antigen (PSMA) PET/CT. This PSMA PET/CT model, combined with MRI and clinical data, offers better preoperative assessment than MRI alone.
Area of Science:
- Urology
- Radiology
- Oncology
Background:
- Extraprostatic extension (EPE) in prostate cancer (PCa) impacts surgical planning, particularly for nerve-sparing radical prostatectomy.
- Current multiparametric MRI (mpMRI)-based nomograms have limited accuracy in predicting EPE.
- There is a need for improved predictive models incorporating advanced imaging like PSMA PET/CT.
Purpose of the Study:
- To evaluate the efficacy of 18F-DCFPyL prostate-specific membrane antigen (PSMA) PET/CT in predicting side-specific EPE in PCa.
- To develop and validate a predictive nomogram integrating PSMA PET/CT parameters with MRI and clinicopathological data.
- To compare the performance of the new PSMA-integrated model against an MRI-only model.
Main Methods:
- A single-center cohort study of 355 patients undergoing robot-assisted radical prostatectomy (RALP) between January 2022 and September 2024.
- Analysis included baseline demographics, PSA, biopsy results, MRI findings, and PSMA PET/CT parameters (SUVmax, EPE, SVI).
- Univariable and multivariable logistic regression were used to identify predictors of EPE, followed by nomogram development and bootstrap validation.
Main Results:
- PSMA PET/CT detected EPE in 5.4% of cases, compared to 18.9% by MRI.
- Higher PSMA SUVmax (median 9.1 vs. 5.4 in EPE-positive vs. negative sides, p<0.001) and specific imaging/pathological features (PIRADS 5, GGG, tumor involvement) were associated with EPE.
- The integrated PSMA+MRI model showed superior performance (AUC 0.7542) compared to the MRI-only model (AUC 0.7350), with strong calibration and clinical utility.
Conclusions:
- A novel nomogram integrating PSMA PET/CT, MRI, and clinicopathological variables significantly improves the prediction of side-specific EPE in prostate cancer.
- PSMA uptake on PET/CT is a strong predictor of EPE, enhancing preoperative assessment.
- Improved EPE prediction can lead to better surgical planning and potentially improved postoperative functional outcomes.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020